ARCHIVES

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012